SPAULDING IQ ELECTROCARDIOGRAPH— 510(k) K110065

Name: FDA 510(k) clearance K110065
Creator: U.S. Food and Drug Administration
Published: 2011-03-02

Substantially Equivalent

Spaulding Clinical Research, LLC

FDA 510(k) clearance K110065 for SPAULDING IQ ELECTROCARDIOGRAPH, Substantially Equivalent on 2011-03-02. Applicant: Spaulding Clinical Research, LLC. Device class: 2.

Clearance details

Applicant: Spaulding Clinical Research, LLC
Product code: Code DPS
Device class: Class 2
Regulation: 21 CFR 870.2340
Advisory panel: Cardiovascular
Date received: 2011-01-10
Decision date: 2011-03-02
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: West Bend, WI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DPS

view all

K252463 — SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)2026-07-02
K251670 — MAC 7 Resting ECG Analysis System2026-01-26
K252361 — AccurECG Analysis System (v2.0)2025-12-22
K252474 — Withings BeamO (SCT02)2025-11-10
K250569 — Cardiologs Holter Platform2025-08-06

More clearances from Spaulding Clinical Research, LLC

view all

K150564 — Spaulding Electrocardiograph 2100iQ2015-08-12

Adverse events under product code DPS

product code DPS

Death: 7
Total: 7

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.